IPR challenges “could eliminate a lot of these patents that are frivolous, which would allow more access to affordable medicines,” Mylan Chief Executive Heather Bresch said in an interview.
chief_executive_officer: Mylan, Heather Bresch; employer: Heather Bresch, Mylan